These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15377848)

  • 1. Mutations of the p53 gene and loss of heterozygosity at chromosome 17p13.1 are associated with increased survivin expression in breast cancer.
    Tsuji N; Furuse K; Asanuma K; Furuya M; Kondoh K; Kamagata C; Sasaki M; Kobayashi D; Yagihashi A; Takahashi H; Watanabe N
    Breast Cancer Res Treat; 2004 Sep; 87(1):23-31. PubMed ID: 15377848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
    Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas.
    Byun DS; Cho K; Ryu BK; Lee MG; Kang MJ; Kim HR; Chi SG
    Cancer Res; 2003 Nov; 63(21):7068-75. PubMed ID: 14612497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cell lung cancer.
    Nakano J; Huang CL; Liu D; Ueno M; Sumitomo S; Yokomise H
    Int J Oncol; 2005 Nov; 27(5):1215-21. PubMed ID: 16211215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
    Libè R; Groussin L; Tissier F; Elie C; René-Corail F; Fratticci A; Jullian E; Beck-Peccoz P; Bertagna X; Gicquel C; Bertherat J
    Clin Cancer Res; 2007 Feb; 13(3):844-50. PubMed ID: 17289876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of BIRC5 is correlated with loss of specific chromosomal regions in breast carcinomas.
    Boidot R; Vegran F; Jacob D; Chevrier S; Gangneux N; Taboureau J; Oudin C; Rainville V; Mercier L; Lizard-Nacol S
    Genes Chromosomes Cancer; 2008 Apr; 47(4):299-308. PubMed ID: 18181175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer.
    Végran F; Boidot R; Oudin C; Defrain C; Rebucci M; Lizard-Nacol S
    Oncogene; 2007 Jan; 26(2):290-7. PubMed ID: 16847456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
    Mirza A; McGuirk M; Hockenberry TN; Wu Q; Ashar H; Black S; Wen SF; Wang L; Kirschmeier P; Bishop WR; Nielsen LL; Pickett CB; Liu S
    Oncogene; 2002 Apr; 21(17):2613-22. PubMed ID: 11965534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
    Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the Hypermethylated in Cancer gene (HIC-1) is associated with good outcome in human breast cancer.
    Nicoll G; Crichton DN; McDowell HE; Kernohan N; Hupp TR; Thompson AM
    Br J Cancer; 2001 Dec; 85(12):1878-82. PubMed ID: 11747329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters.
    Seitz S; Poppe K; Fischer J; Nothnagel A; Estévez-Schwarz L; Haensch W; Schlag PM; Scherneck S
    J Pathol; 2001 Jul; 194(3):318-26. PubMed ID: 11439364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct expression of Survivin splice variants in breast carcinomas.
    Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
    Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene.
    Liscia DS; Morizio R; Venesio T; Palenzona C; Donadio M; Callahan R
    Br J Cancer; 1999 May; 80(5-6):821-6. PubMed ID: 10360661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers.
    Eiriksdottir G; Barkardottir RB; Agnarsson BA; Johannesdottir G; Olafsdottir K; Egilsson V; Ingvarsson S
    Oncogene; 1998 Jan; 16(1):21-6. PubMed ID: 9467939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct promoter usage of mdm2 gene in human breast cancer.
    Okumura N; Saji S; Eguchi H; Nakashima S; Saji S; Hayashi S
    Oncol Rep; 2002; 9(3):557-63. PubMed ID: 11956627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours.
    Chattopadhyay P; Rathore A; Mathur M; Sarkar C; Mahapatra AK; Sinha S
    Oncogene; 1997 Aug; 15(7):871-4. PubMed ID: 9266974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis gene signature of Survivin and its splice variant expression in breast carcinoma.
    Végran F; Boidot R; Bonnetain F; Cadouot M; Chevrier S; Lizard-Nacol S
    Endocr Relat Cancer; 2011 Dec; 18(6):783-92. PubMed ID: 21878572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of {gamma}-aminobutyric acid type A receptor-associated protein, a novel tumor suppressor, showing reduced expression in breast cancer.
    Klebig C; Seitz S; Arnold W; Deutschmann N; Pacyna-Gengelbach M; Scherneck S; Petersen I
    Cancer Res; 2005 Jan; 65(2):394-400. PubMed ID: 15695379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.